Intest Res.  2021 Apr;19(2):206-216. 10.5217/ir.2019.09169.

Colitis and Crohn’s Foundation (India): a first nationwide inflammatory bowel disease registry

• Sood A
• Kaur K
• Mahajan R
• Midha V
• Singh A
• Sharma S
• Puri AS
• Goswami B
• Desai D
• Pai CG
• Peddi K
• Philip M
• Kochhar R
• Nijhawan S
• Bhatia S
• Rao NS

• KMID: 2515479
• DOI: http://doi.org/10.5217/ir.2019.09169

Abstract

Background/Aims
The national registry for inflammatory bowel disease (IBD) was designed to study epidemiology and prescribing pattern of treatment of IBD in India.
Methods
A multicenter, cross-sectional, prospective registry was established across four geographical zones of India. Adult patients with ulcerative colitis (UC) or Crohn’s disease (CD) were enrolled between January 2014 and December 2015. Information related to demographics; disease features; complications; and treatment history were collected and analyzed.
Results
A total of 3,863 patients (mean age, 36.7 ± 13.6 years; 3,232 UC [83.7%] and 631 CD [16.3%]) were enrolled. The majority of patients with UC (n = 1,870, 57.9%) were from north, CD was more common in south (n = 348, 55.5%). The UC:CD ratio was 5.1:1. There was a male predominance (male:female = 1.6:1). The commonest presentation of UC was moderately severe (n = 1,939, 60%) and E2 disease (n = 1,895, 58.6%). Patients with CD most commonly presented with ileocolonic (n = 229, 36.3%) inflammatory (n = 504, 79.9%) disease. Extraintestinal manifestations were recorded among 13% and 20% of patients in UC and CD respectively. Less than 1% patients from both cohorts developed colon cancer (n = 26, 0.7%). The commonly used drugs were 5-aminosalicylates (99%) in both UC and CD followed by azathioprine (34.4%). Biologics were used in only 1.5% of patients; more commonly for UC in north and CD in south.
Conclusions
The national IBD registry brings out diversities in the 4 geographical zones of India. This will help in aiding research on IBD and improving quality of patient care.

Keyword

Inflammatory bowel disease; National registry; Colitis, ulcerative; India; Crohn disease

Figure

• 

Reference

1. Solomon DH, Shadick NA, Weinblatt ME, et al. Clinical patient registry recruitment and retention: a survey of patients in two chronic disease registries. BMC Med Res Methodol. 2017; 17:59.

2. Bergqvist D, Björck M, Säwe J, Troëng T. Randomized trials or population-based registries. Eur J Vasc Endovasc Surg. 2007; 34:253–256.

3. Gordon H, Langholz E. The EpiCom survey: registries across Europe, epidemiological research and beyond. J Crohns Colitis. 2017; 11:1019–1021.

4. Winter DA, Karolewska-Bochenek K, Lazowska-Przeorek I, et al. Pediatric IBD-unclassified is less common than previously reported; results of an 8-year audit of the EUROKIDS registry. Inflamm Bowel Dis. 2015; 21:2145–2153.

5. Ng SC, Tang W, Ching JY, et al. Incidence and phenotype of inflammatory bowel disease based on results from the Asiapacific Crohn’s and colitis epidemiology study. Gastroenterology. 2013; 145:158–165.

6. Ahuja V, Tandon RK. Inflammatory bowel disease in the AsiaPacific area: a comparison with developed countries and regional differences. J Dig Dis. 2010; 11:134–147.

7. Al-Shamali MA, Kalaoui M, Patty I, Hasan F, Khajah A, Al-Nakib B. Ulcerative colitis in Kuwait: a review of 90 cases. Digestion. 2003; 67:218–224.

8. Tezel A, Dökmeci G, Eskiocak M, Umit H, Soylu AR. Epidemiological features of ulcerative colitis in Trakya, Turkey. J Int Med Res. 2003; 31:141–148.

9. Niv Y, Abuksis G, Fraser GM. Epidemiology of ulcerative colitis in Israel: a survey of Israeli kibbutz settlements. Am J Gastroenterol. 2000; 95:693–698.

10. Das K, Ghoshal UC, Dhali GK, Benjamin J, Ahuja V, Makharia GK. Crohn’s disease in India: a multicenter study from a country where tuberculosis is endemic. Dig Dis Sci. 2009; 54:1099–1107.

11. Munkholm P, Langholz E, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of Crohn’s disease in the county of Copenhagen, 1962-87: a sixfold increase in incidence. Scand J Gastroenterol. 1992; 27:609–614.

12. Langholz E, Munkholm P, Nielsen OH, Kreiner S, Binder V. Incidence and prevalence of ulcerative colitis in Copenhagen county from 1962 to 1987. Scand J Gastroenterol. 1991; 26:1247–1256.

13. Silverberg MS, Satsangi J, Ahmad T, et al. Toward an integrated clinical, molecular and serological classification of inflammatory bowel disease: report of a Working Party of the 2005 Montreal World Congress of Gastroenterology. Can J Gastroenterol. 2005; 19 Suppl A:5A–36A.

14. Satsangi J, Silverberg MS, Vermeire S, Colombel JF. The Montreal classification of inflammatory bowel disease: controversies, consensus, and implications. Gut. 2006; 55:749–753.

15. Schroeder KW, Tremaine WJ, Ilstrup DM. Coated oral 5-aminosalicylic acid therapy for mildly to moderately active ulcerative colitis: a randomized study. N Engl J Med. 1987; 317:1625–1629.

16. Harvey RF, Bradshaw JM. A simple index of Crohn’s-disease activity. Lancet. 1980; 1:514.

17. Singh P, Ananthakrishnan A, Ahuja V. Pivot to Asia: inflammatory bowel disease burden. Intest Res. 2017; 15:138–141.

18. Kedia S, Ahuja V. Epidemiology of inflammatory bowel disease in India: the great shift East. Inflamm Intest Dis. 2017; 2:102–115.

19. Basu A, Sarkar-Roy N, Majumder PP. Genomic reconstruction of the history of extant populations of India reveals five distinct ancestral components and a complex structure. Proc Natl Acad Sci U S A. 2016; 113:1594–1599.

20. Juyal G, Prasad P, Senapati S, et al. An investigation of genomewide studies reported susceptibility loci for ulcerative colitis shows limited replication in north Indians. PLoS One. 2011; 6:e16565.

21. Juyal G, Negi S, Sood A, et al. Genome-wide association scan in north Indians reveals three novel HLA-independent risk loci for ulcerative colitis. Gut. 2015; 64:571–579.

22. Liu JZ, van Sommeren S, Huang H, et al. Association analyses identify 38 susceptibility loci for inflammatory bowel disease and highlight shared genetic risk across populations. Nat Genet. 2015; 47:979–986.

23. Baskaran K, Pugazhendhi S, Ramakrishna BS. Association of IRGM gene mutations with inflammatory bowel disease in the Indian population. PLoS One. 2014; 9:e106863.

24. Juyal G, Mondal M, Luisi P, et al. Population and genomic lessons from genetic analysis of two Indian populations. Hum Genet. 2014; 133:1273–1287.

25. To N, Gracie DJ, Ford AC. The importance of smoking cessation in improving disease course in Crohn’s disease. Am J Gastroenterol. 2016; 111:1198.

26. Kuenzig ME, Lee SM, Eksteen B, et al. Smoking influences the need for surgery in patients with the inflammatory bowel diseases: a systematic review and meta-analysis incorporating disease duration. BMC Gastroenterol. 2016; 16:143.

27. Probert CS, Jayanthi V, Pinder D, Wicks AC, Mayberry JF. Epidemiological study of ulcerative proctocolitis in Indian migrants and the indigenous population of Leicestershire. Gut. 1992; 33:687–693.

28. Vecchio MG, Paramesh EC, Paramesh H, et al. Types of food and nutrient intake in India: a literature review. Indian J Pediatr. 2014; 81 Suppl 1:17–22.

29. Green R, Milner J, Joy EJ, Agrawal S, Dangour AD. Dietary patterns in India: a systematic review. Br J Nutr. 2016; 116:142–148.

30. Sonnenberg A. Age distribution of IBD hospitalization. Inflamm Bowel Dis. 2010; 16:452–457.

31. Duricova D, Burisch J, Jess T, Gower-Rousseau C, Lakatos PL; ECCO-EpiCom. Age-related differences in presentation and course of inflammatory bowel disease: an update on the population-based literature. J Crohns Colitis. 2014; 8:1351–1361.

32. Kalaria R, Desai D, Abraham P, Joshi A, Gupta T, Shah S. Temporal change in phenotypic behaviour in patients with Crohn’s disease: do Indian patients behave differently from Western and other Asian patients? J Crohns Colitis. 2016; 10:255–261.

33. Malekzadeh MM, Sima A, Alatab S, et al. Iranian Registry of Crohn’s and Colitis: study profile of first nation-wide inflammatory bowel disease registry in Middle East. Intest Res. 2019; 17:330–339.

34. Yang SK, Yun S, Kim JH, et al. Epidemiology of inflammatory bowel disease in the Songpa-Kangdong district, Seoul, Korea, 1986-2005: a KASID study. Inflamm Bowel Dis. 2008; 14:542–549.

35. Asakura K, Nishiwaki Y, Inoue N, Hibi T, Watanabe M, Takebayashi T. Prevalence of ulcerative colitis and Crohn’s disease in Japan. J Gastroenterol. 2009; 44:659–665.

36. Makharia GK, Ramakrishna BS, Abraham P, et al. Survey of inflammatory bowel diseases in India. Indian J Gastroenterol. 2012; 31:299–306.

37. Ng SC, Leung WK, Shi HY, et al. Epidemiology of inflammatory bowel disease from 1981 to 2014: results from a territorywide population-based registry in Hong Kong. Inflamm Bowel Dis. 2016; 22:1954–1960.

38. Childers RE, Eluri S, Vazquez C, Weise RM, Bayless TM, Hutfless S. Family history of inflammatory bowel disease among patients with ulcerative colitis: a systematic review and meta-analysis. J Crohns Colitis. 2014; 8:1480–1497.